Table 1 Demographic characteristics.
Variables | Total (n = 1,080) | ≤7 METs (n = 131) | >7 METs (n = 949) | P value* |
|---|---|---|---|---|
Age (years) | 65 ± 11 | 71 ± 8 | 64 ± 11 | <0.0001 |
Age <65 | 509 (47.1) | 23 (17.6) | 486 (51.2) | <0.0001 |
Age 65–74 | 391 (36.2) | 64 (48.9) | 327 (34.5) | 0.001 |
Age ≥75 | 180 (16.7) | 44 (33.6) | 136 (14.3) | <0.0001 |
Male | 769 (71.2) | 70 (53.4) | 699 (73.7) | <0.0001 |
Body mass index (kg/m2) | 24.9 ± 3.2 | 25.5 ± 3.7 | 24.8 ± 3.1 | 0.048 |
Duration of AF ( ≥ 3 months) | 932 (86.3) | 114 (87.0) | 818 (86.2) | 0.893 |
Type of AF | ||||
Paroxysmal | 817 (75.6) | 89 (67.9) | 728 (76.7) | 0.028 |
Persistent | 234 (21.7) | 40 (30.5) | 194 (20.4) | 0.009 |
Permanent | 29 (2.7) | 2 (1.5) | 27 (2.8) | 0.566 |
Diabetes mellitus | 263 (24.4) | 48 (36.6) | 215 (22.7) | <0.0001 |
Hypertension | 747 (69.4) | 114 (87.0) | 633 (66.9) | <0.0001 |
Stroke/TIA | 111 (10.3) | 97 (10.2) | 14 (10.7) | 0.892 |
Peripheral artery disease | 22 (22.0) | 5 (3.8) | 17 (1.8) | 0.174 |
Dyslipidemia | 437 (40.7) | 54 (41.5) | 383 (40.5) | 0.826 |
Chronic kidney disease | 100 (9.3) | 20 (15.3) | 80 (8.4) | 0.011 |
Smoking | 405 (37.5) | 41 (31.3) | 364 (38.4) | 0.118 |
Medications | ||||
ACEi or ARB | 381 (35.3) | 65 (49.6) | 316 (33.3) | <0.0001 |
Beta-blocker | 529 (49.0) | 72 (55.0) | 457 (48.2) | 0.144 |
Calcium channel blocker | 339 (31.4) | 59 (45.0) | 280 (29.5) | <0.0001 |
Digoxin | 35 (3.2) | 7 (5.3) | 28 (3.0) | 0.181 |
Antiarrhythmic drug | 624 (57.8) | 70 (53.4) | 554 (58.4) | 0.283 |
